marimastat has been researched along with Stomach Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, M; Igarashi, N; Kameyama, K; Kimata, M; Kitajima, M; Kubota, T; Kumai, K; Okada, Y; Otani, Y; Wada, N; Yokoyama, T; Yoshimizu, N | 1 |
| Fujii, M; Furukawa, T; Kameyama, K; Kimata, M; Kitajima, M; Kubota, T; Kumai, K; Minagawa, A; Okada, Y; Otani, Y; Saikawa, Y; Wada, N; Yoshida, M; Yoshimizu, N | 1 |
| Caponigro, F; Facchini, G; Iaffaioli, RV; Nasti, G | 1 |
| Davis, TR; Hutchinson, JW; Parsons, SL; Tierney, GM | 1 |
| Igarashi, N; Kameyama, K; Kimata, D; Kitajima, M; Kubota, T; Kumai, K; Okada, Y; Otani, Y; Wada, N; Yokoyama, T | 1 |
| Bawden, LJ; Bone, EA; Collins, HM; Hawkins, K; Morris, TM; Watson, SA | 1 |
| Brown, PD; Griffin, NR; Kasem, H; Lury, JT; Lynch, KP; Millar, AW; Parsons, SL; Steele, RJ; Stuart, RC; Tierney, GM | 1 |
| Adachi, Y; Imai, K; Itoh, F | 1 |
| Baillet, M; Bramhall, SR; Brown, PD; Fielding, JW; Hallissey, MT; Hawkins, RE; Maughan, T; McCulloch, P; Scholefield, J; Stuart, RC; Tierney, G; Whiting, J | 1 |
2 review(s) available for marimastat and Stomach Neoplasms
| Article | Year |
|---|---|
Gastric cancer. Treatment of advanced disease and new drugs.
Topics: Antineoplastic Agents; Camptothecin; Docetaxel; Drug Therapy; Humans; Hydroxamic Acids; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids | 2005 |
[Matrix metalloproteinase in human gastric carcinoma].
Topics: Biomarkers, Tumor; Hydroxamic Acids; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Neoplasm Invasiveness; Neoplasm Metastasis; Stomach Neoplasms; Tissue Inhibitor of Metalloproteinases | 2001 |
1 trial(s) available for marimastat and Stomach Neoplasms
| Article | Year |
|---|---|
Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial.
Topics: Adenocarcinoma; Adult; Aged; Case-Control Studies; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Hydroxamic Acids; L-Lactate Dehydrogenase; Male; Metalloendopeptidases; Middle Aged; Safety; Stomach Neoplasms; Survival Rate; Tissue Distribution; Treatment Outcome | 2002 |
7 other study(ies) available for marimastat and Stomach Neoplasms
| Article | Year |
|---|---|
Matrix metalloproteinase inhibitor, marimastat, decreases peritoneal spread of gastric carcinoma in nude mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Body Weight; Cell Survival; Coloring Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hydroxamic Acids; Male; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Models, Chemical; Neoplasm Metastasis; Neoplasm Transplantation; Peritoneum; Stomach Neoplasms; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured | 2002 |
Reduced angiogenesis in peritoneal dissemination of gastric cancer through gelatinase inhibition.
Topics: Animals; Enzyme Inhibitors; Gelatinases; Humans; Hydroxamic Acids; Immunohistochemistry; Mice; Mice, SCID; Microcirculation; Neovascularization, Pathologic; Osmosis; Peritoneum; Platelet Endothelial Cell Adhesion Molecule-1; Stomach Neoplasms; Time Factors; Tumor Cells, Cultured | 2003 |
Dupuytren's disease and frozen shoulder induced by treatment with a matrix metalloproteinase inhibitor.
Topics: Adenocarcinoma; Bursitis; Dupuytren Contracture; Enzyme Inhibitors; Humans; Hydroxamic Acids; Male; Metalloendopeptidases; Stomach Neoplasms | 1998 |
[Antitumor effect of a matrix metalloproteinase inhibitor, TA-2516 (Marimastat), on a nude mouse model of intraperitoneal seeding of stomach cancer].
Topics: Animals; Antineoplastic Agents; Hydroxamic Acids; Male; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Seeding; Stomach Neoplasms | 1999 |
Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA.
Topics: Animals; Antineoplastic Agents; Carcinoembryonic Antigen; Cell Division; Enzyme Inhibitors; Female; Growth Inhibitors; Humans; Hydroxamic Acids; Male; Metalloendopeptidases; Mice; Mice, Nude; Neoplasm Transplantation; Stomach Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 1999 |
A pilot study of the safety and effects of the matrix metalloproteinase inhibitor marimastat in gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hydroxamic Acids; Metalloendopeptidases; Middle Aged; Pilot Projects; Stomach Neoplasms; Treatment Outcome | 1999 |
Marimastat. BB 2516, TA 2516.
Topics: Adult; Antineoplastic Agents; Colorectal Neoplasms; Drugs, Investigational; Female; Humans; Hydroxamic Acids; Male; Melanoma; Metalloendopeptidases; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Protease Inhibitors; Stomach Neoplasms | 1999 |